{"interviewQueryText":"What are some good interview questions in British English for the job description below?\n\n-------------------------------------------\n\nClinical Fellow – Stereotactic Ablative Body Radiotherapy (SABR) with The Christie NHS FT in Manchester\n\n ORGANISATIONAL ARRANGEMENTSThis post is for 40 hours per week as a Clinical Fellow for the development and implementation of Stereotactic Ablative Body Radiotherapy (SABR) within the organisation for a fixed term period of 12 months with the option to extend for a further 12 months. The post holder will be employed by The Christie NHS Foundation Trust and will be based at The Christie. Role PurposeThe successful applicant would be expected to work alongside consultants and trainees in out-patient clinics across a number of disease groups, supervising Technical Radiotherapy delivery and performing on-treatment reviews and follow-up assessments. The role will be responsible for: The appointee will be a Fellow in the department of Clinical Oncology The employing authority is The Christie NHS Foundation Trust S/he will be managerially accountable to the Clinical Director of the Directorate of Clinical Oncology S/he will be professionally responsible to the consultants in whose clinics s/he will be supporting. The post-holder will be assigned a clinical supervisor (Consultant Clinical Oncologist). They will work alongside their supervisor in at least one clinic. Will develop expertise in the development, management and treatment of HPB and oligometastatic tumour sites with SABR DUTIES AND RESPONSIBILITIESThe medical establishment provides currently consists of 59 Consultants who run the clinical service and research practice. There is also a team of 23 SpRs plus Academic Clinical Fellows. The appointee will be based at The Christie and will provide senior input to all aspects of the management of patients with HBT and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated SABR team consultant They will be expected to teach junior medical staff, medical students and nurses on occasion. They will be expected to take part in audit and research. Continuing Professional DevelopmentThe Trust supports the requirements for continuing professional development (CPD) as laid down by the GMC and surgical colleges and is committed to providing time and financial support for these activities. Role PlanningThe timetable below is indicative and will be confirmed on commencement in post. Monday Tuesday Wednesday Thursday Friday AM Clinic TBS review clinic Admin / Liver SABR MDT Clinic/ Pelvic MDT Renal SABR MDT ( alt weeks) Radiotherapy planning PM Admin / Bone SABR MDT Clinic Radiotherapy planning Admin Training NB This timetable is indicative On call CommitmentsThis role does not require participation in the on-call rota. The Christie NHS Foundation Trust serves a population of 3 million people within the Greater Manchester and Cheshire Cancer Network, providing surgery, radiotherapy and complex chemotherapy services.Applications are welcomed for a 12 month SABR clinical fellow post in Clinical Oncology, based at The Christie NHS FT, Manchester, UK Europe's largest single site cancer hospital.This post is for 40 hours per week as a Clinical Fellow for the development and implementation of Stereotactic Ablative Body Radiotherapy (SABR) within the organisation for a fixed term period of 12 months with the option to extend for a further 12 months. The post holder will be employed by The Christie NHS Foundation Trust and will be based at The Christie. The successful applicant would be expected to work alongside consultants and trainees in out-patient clinics, supervising Technical Radiotherapy delivery and performing on-treatment reviews and follow-up assessments. The post holder will be involved in all aspects of the management of patients with HBT and oligometastatic disease. These include (but are not limited to) the screening of referrals, active participation in MDT, assessment of patients, consent, review of patients on pre-treatment, treatment, planning of SABR, review and approval of SABR plans, technical radiotherapy development and post treatment and ePROMS. All of this will be done under the clinical supervision of the designated SABR team consultant.They will be expected to teach junior medical staff, medical students and nurses on occasion.They will be expected to take part in audit and research.There is no on call responsibility with this post. "}